George Kemble - 07 Sep 2023 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
Executive Chairman, Director
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Issuer symbol
SGMT
Transactions as of
07 Sep 2023
Net transactions value
+$4,448
Form type
4
Filing time
08 Sep 2023, 16:15:41 UTC
Previous filing
20 Jul 2023
Next filing
21 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGMT Series A Common Stock Options Exercise $4,448 +5,630 $0.7900* 5,630 07 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGMT Stock Option (Right to Buy) Options Exercise $0 -5,630 -100% $0.000000* 0 07 Sep 2023 Series A Common Stock 5,630 $0.7900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable as of the date hereof.